These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

344 related items for PubMed ID: 17202815

  • 1. Applications of a blood-brain barrier technology platform to predict CNS penetration of various chemotherapeutic agents. 2. Cationic peptide vectors for brain delivery.
    Adenot M, Merida P, Lahana R.
    Chemotherapy; 2007; 53(1):73-6. PubMed ID: 17202815
    [Abstract] [Full Text] [Related]

  • 2. Applications of a blood-brain barrier technology platform to predict CNS penetration of various chemotherapeutic agents. 1. Anti-infective drugs.
    Adenot M, Perriere N, Scherrmann JM, Lahana R.
    Chemotherapy; 2007; 53(1):70-2. PubMed ID: 17202814
    [Abstract] [Full Text] [Related]

  • 3. Peptide-derivatized biodegradable nanoparticles able to cross the blood-brain barrier.
    Costantino L, Gandolfi F, Tosi G, Rivasi F, Vandelli MA, Forni F.
    J Control Release; 2005 Nov 02; 108(1):84-96. PubMed ID: 16154222
    [Abstract] [Full Text] [Related]

  • 4. Nanobiotechnology-based drug delivery to the central nervous system.
    Jain KK.
    Neurodegener Dis; 2007 Nov 02; 4(4):287-91. PubMed ID: 17627131
    [Abstract] [Full Text] [Related]

  • 5. Delivery of therapeutic agents to the central nervous system: the problems and the possibilities.
    Begley DJ.
    Pharmacol Ther; 2004 Oct 02; 104(1):29-45. PubMed ID: 15500907
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Differential receptor-mediated drug targeting to the diseased brain.
    Rip J, Schenk GJ, de Boer AG.
    Expert Opin Drug Deliv; 2009 Mar 02; 6(3):227-37. PubMed ID: 19327042
    [Abstract] [Full Text] [Related]

  • 9. Large amino acid transporter 1 (LAT1) prodrugs of valproic acid: new prodrug design ideas for central nervous system delivery.
    Peura L, Malmioja K, Laine K, Leppänen J, Gynther M, Isotalo A, Rautio J.
    Mol Pharm; 2011 Oct 03; 8(5):1857-66. PubMed ID: 21770378
    [Abstract] [Full Text] [Related]

  • 10. Progress in brain penetration evaluation in drug discovery and development.
    Liu X, Chen C, Smith BJ.
    J Pharmacol Exp Ther; 2008 May 03; 325(2):349-56. PubMed ID: 18203948
    [Abstract] [Full Text] [Related]

  • 11. The targeted delivery of cancer drugs across the blood-brain barrier: chemical modifications of drugs or drug-nanoparticles?
    Juillerat-Jeanneret L.
    Drug Discov Today; 2008 Dec 03; 13(23-24):1099-106. PubMed ID: 18848640
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Targeting the central nervous system: in vivo experiments with peptide-derivatized nanoparticles loaded with Loperamide and Rhodamine-123.
    Tosi G, Costantino L, Rivasi F, Ruozi B, Leo E, Vergoni AV, Tacchi R, Bertolini A, Vandelli MA, Forni F.
    J Control Release; 2007 Sep 11; 122(1):1-9. PubMed ID: 17651855
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Dual-targeting topotecan liposomes modified with tamoxifen and wheat germ agglutinin significantly improve drug transport across the blood-brain barrier and survival of brain tumor-bearing animals.
    Du J, Lu WL, Ying X, Liu Y, Du P, Tian W, Men Y, Guo J, Zhang Y, Li RJ, Zhou J, Lou JN, Wang JC, Zhang X, Zhang Q.
    Mol Pharm; 2009 Sep 11; 6(3):905-17. PubMed ID: 19344115
    [Abstract] [Full Text] [Related]

  • 16. Transport of histone through the blood-brain barrier.
    Pardridge WM, Triguero D, Buciak J.
    J Pharmacol Exp Ther; 1989 Dec 11; 251(3):821-6. PubMed ID: 2600816
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Blood-brain barrier permeability considerations for CNS-targeted compound library design.
    Hitchcock SA.
    Curr Opin Chem Biol; 2008 Jun 11; 12(3):318-23. PubMed ID: 18435937
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.